Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Submitted by
admin
on June 23, 2014 - 12:53pm
Source:
Fierce Pharma
News Tags:
Amgen
Epogen
anemia
Procrit
JNJ
Headline:
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Do Not Allow Advertisers to Use My Personal information
